Date: Tuesday 11th February
Time: 12:30-14:00pm
Venue: Clifford Allbutt Building, Cambridge Biomedical Campus, CB2 0AH
Register at: https://eci-seminar-robert-rintoul.eventbrite.co.uk
The ECI seminar series aims to highlight early cancer related research across a range of disciplines, promote discussion and inspire new ideas and connections. Join fellow researchers for lunch and an opportunity to network.
On Tuesday 11th February we are joined by Robert Rintoul, Professor of Thoracic Oncology, University of Cambridge and Honorary Consultant Respiratory Physician, Royal Papworth Hospital.
Robert will speak on: Lung cancer screening - what you need to know
This event will take place in the Clifford Allbutt Building lecture theatre, Cambridge Biomedical Campus, Cambridge, CB2 0AH
A buffet lunch will be served from 12.30pm in the foyer outside the lecture theatre and the talk will begin at 1.00pm followed by a Q&A. Please ensure you arrive promptly.
Please note that no food or drink may be taken into the lecture theatre.
Speaker biography
Robert Rintoul is Professor of Thoracic Oncology in the Department of Oncology, University of Cambridge and Honorary Consultant Respiratory Physician, Royal Papworth Hospital. He qualified in medicine from the University of Edinburgh having undertaken his pre-clinical training at the University of St Andrews. He subsequently trained in respiratory medicine in London and Edinburgh receiving his doctorate from the University of Edinburgh for research investigating mechanisms underlying resistance to chemotherapy in small cell lung cancer.
He was appointed consultant in respiratory medicine specialising in thoracic oncology at Royal Papworth Hospital in 2005 before moving to the University of Cambridge in 2017. Prof Rintoul is co-lead of the Thoracic Cancer Programme of the Cancer Research UK Cambridge Cancer Centre and Director of the Papworth Trials Unit Collaboration, a UKCRC registered clinical trials unit. Since 2021 he has been the clinical lead of the Clinical Advisory Group of the UK Lung Cancer Coalition. Since 2023 he has been clinical director for the Cambridgeshire and Peterborough lung cancer screening programme.
Prof Rintoul runs programmes of research in early-stage lung cancer and pleural mesothelioma. In lung cancer his work is predominantly focussed on translational clinical trials in biomarker discovery for early detection of primary and second primary lung cancer. In 2014 he founded Mesobank UK, the UK national bioresource for malignant mesothelioma (www.mesobank.com) which is also developing and characterising novel organoid models. His research is funded by NIHR Cambridge Biomedical Research Centre, Cancer Research UK, Medical Research Council and Asthma and Lung UK.